7AC.F ACARIX AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0080 EUR
Close of Nov 9, 2026
0.0080 0.0298
Market cap
EUR 9.92M
P/E
-
P/B
2.49x
ROE
-83.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 7AC.F undervalued?

Graham number

The Graham number of ACARIX AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ACARIX AB fundamental analysis

No fundamental analysis for ACARIX AB yet.

ACARIX AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ACARIX AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is …

Full company profile